Skip to main content
HRES 335 110th Congress House Health Armed Forces and National Security Case management Centers for Disease Control and Prevention (CDC) Chemotherapy Department of Health and Human Services Drug abuse Economics and Public Finance Education Executive reorganization Federal advisory bodies Federal aid to research Federal officials Government Operations and Politics Graduate education Health surveys Higher education Imaging systems in medicine Lung cancer Medicaid

Expressing the sense of the House of Representatives with respect to lung cancer as a public health priority and the recommendations of the Lung Cancer Progress Review Group of the National Cancer Institute.

Introduced: April 24, 2007 See on congress.gov
 Everywhere this bill has been 10 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 13, 2007
The title of the measure was amended. Agreed to without objection.
Nov 13, 2007
Motion to reconsider laid on the table Agreed to without objection.
Nov 13, 2007
On motion to suspend the rules and agree to the resolution, as amended Agreed to by voice vote. (text: CR H13545)
Nov 13, 2007
Passed/agreed to in House: On motion to suspend the rules and agree to the resolution, as amended Agreed to by voice vote.(text: CR H13545)
Nov 13, 2007
DEBATE - The House proceeded with forty minutes of debate on H. Res. 335.
Nov 13, 2007
Considered under suspension of the rules. (consideration: CR H13545-13546)
Nov 13, 2007
Mrs. Capps moved to suspend the rules and agree to the resolution, as amended.
Apr 25, 2007
Referred to the Subcommittee on Health.
Apr 24, 2007
Referred to the House Committee on Energy and Commerce.
Apr 24, 2007
Introduced in House
 Plain-English summary Congressional Research Service

Recognizes: (1) lung cancer as a public health priority; (2) the importance of reducing the lung cancer mortality rate by at least half by 2015; (3) the benefit of graduate medical education programs in thoracic medicine and cardiothoracic surgery; and (4) the importance of the recommendations of the Lung Cancer Progress Review Group of the National Cancer Institute.

Encourages increased investment for lung cancer research and other lung cancer-related programs.

Expresses support for efforts to develop a broad-based lung cancer screening and disease management program among members of the Armed Forces and veterans.

What's happening now November 13, 2007

The title of the measure was amended. Agreed to without objection.

 Committees of jurisdiction 2